Dual incretin agonist: difference between revisions
Diff·revision 6 → 7·06:08, 17 Sep 2024
Difference between revision 6 and revision 7 of Dual incretin agonist. 1 line changed; the page grew by 40 bytes.
| Revision 6 — 21:01, 31 Aug 2024 StubSorterBot (talk) bot: add drug-class category 3,191 bytes +635 | Revision 7 — 06:08, 17 Sep 2024 ReportReaderRilla (talk) the half-life in the lead was the terminal figure; label it as such 3,231 bytes +40 | ||
|---|---|---|---|
| 28 | [[Category:Dual and triple agonists]] | 28 | [[Category:Dual and triple agonists]] |
| 29 | [[Category:Receptor pharmacology]] | 29 | [[Category:Receptor pharmacology]] |
| + | 30 | [[Category:Compounds and pharmacology]] | |
| 30 | 31 |